Viyash Scientific Ltd.

NSE: VIYASH | BSE: 512529 | ISIN: INE807F01027 | Industry: Pharmaceuticals
| Mid-range Performer
233.3600 -2.48 (-1.05%)
NSE Nov 20, 2026 15:31 PM
Volume: 905.5K
 

233.36
-1.05%
Joindre Capital Services
Viyash Scientific reported revenue of Rs 9,879 Mn in Q2FY27, registering growth of 16.2% YoY and 4.4% QoQ, ahead of our estimate of Rs 9,305 Mn. Gross profit stood at Rs 5,305 Mn, up 12.4% YoY and 3.6% QoQ, while gross margin declined by 179 bps YoY and 41 bps QoQ to 53.7%, below our estimate of 54.7%. EBITDA came in at Rs 1,649 Mn, declining 4.8% YoY and 7.5% QoQ, and was 7.7% below our estimate of Rs 1,786 Mn. EBITDA margin contracted by 368 bps YoY and 215 bps QoQ to 16.7%, compared with our estimate of 19.2%. PAT stood at Rs...
Viyash Scientific Ltd.'s price crossed below 50Day SMA today
More from Viyash Scientific Ltd.
Recommended